Aicardi-Goutières syndrome: Clues from the RNase H2 knock-out mouse

Journal of Molecular Medicine

Volumn 91, Issue 11, 2013, Pages 1235-1240

  Rabe, Björn ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Aicardi Gouti res syndrome; Autoimmunity; Interferon ; RNase H2

Indexed keywords

ADAR1 PROTEIN; ALPHA INTERFERON; GENOMIC DNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; RIBONUCLEASE; RIBONUCLEASE H2; RIBONUCLEOTIDE; SAMHD1 PROTEIN; TREX1 PROTEIN; UNCLASSIFIED DRUG;

AICARDI GOUTIERES SYNDROME; ANIMAL EXPERIMENT; AUTOIMMUNITY; CELL FUNCTION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GASTRULATION; GENE; GENE MUTATION; GROWTH DISORDER; MOUSE; NONHUMAN; NUCLEIC ACID METABOLISM; PATHOGENESIS; REVIEW; UPREGULATION;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; DNA DAMAGE; HUMANS; MICE; MICE, KNOCKOUT; NERVOUS SYSTEM MALFORMATIONS; RIBONUCLEASE H;

EID: 84888643317     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1061-x     Document Type: Review

References (54)

1. Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, Artuch R, Montalto SA, Bacino CA, Barroso B et al (2007) Clinical and molecular phenotype of Aicardi-Goutières syndrome. Am J Hum Genet 81:713-725
2. McEntagart M, Kamel H, Lebon P, King MD (1998) Aicardi-Goutières syndrome: an expanding phenotype. Neuropediatrics 29:163-167
3. Aicardi J, Goutieres F (1984) A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 15:49-54
4. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA et al (2009) Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41:829-832
5. Xin B, Jones S, Puffenberger EG, Hinze C, Bright A, Tan H, Zhou A, Wu G, Vargus-Adams J, Agamanolis D et al (2011) Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci U S A 108:5372-5377
6. Crow YJ, Rehwinkel J (2009) Aicardi-Goutières syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 18:R130-R136
7. Rigby RE, Leitch A, Jackson AP (2008) Nucleic acid-mediated inflammatory diseases. Bioessays 30:833-842
8. Crow Y, Hayward B, Parmar R, Robins P, Leitch A, Ali M, Black D, van Bokhoven H, Brunner H, Hamel B et al (2006) Mutations in the gene encoding the 3-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet 38:917-920
9. Crow Y, Leitch A, Hayward B, Garner A, Parmar R, Griffith E, Ali M, Semple C, Aicardi J, Babul-Hirji R et al (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet 38:910-916
10. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA et al (2012) Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet 44:1243-1248
11. Stetson DB, Medzhitov R (2006) Type I interferons in host defense. Immunity 25:373-381
12. Goutieres F, Aicardi J, Barth PG, Lebon P (1998) Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. AnnNeurol 44:900-907
13. Van Heteren JT, Rozenberg F, Aronica E, Troost D, Lebon P, Kuijpers TW (2008) Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutières syndrome. Glia 56:568-578
14. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100:2610-2615
15. Liu Z, Davidson A (2012) Taming lupus - a new understanding of pathogenesis is leading to clinical advances. Nat Med 18:871-882
16. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280-289
17. Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, Borozdin W, Mah JK, Ungerath K, Walkenhorst H et al (2010) Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis Rheum 62:1469-1477
18. Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, Robins P, Harvey S, Hollis T, O'Hara A et al (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutières syndrome. Am J Hum Genet 80:811-815
19. Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, Pfeiffer C, Hollis T, Gahr M, Perrino FW et al (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med 85:531-537
20. Ravenscroft JC, Suri M, Rice GI, Szynkiewicz M, Crow YJ (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet A 155A:235-237
21. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey SL, Witte T, Vyse TJ et al (2007) Mutations in the gene encoding the 3-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39:1065-1067
22. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcon-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA et al (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12(4):270-279. doi: 10.1038/gene.2010.73, Epub 2011 Jan 27
23. Campbell IL, Krucker T, Steffensen S, Akwa Y, Powell HC, Lane T, Carr DJ, Gold LH, Henriksen SJ, Siggins GR (1999) Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res 835:46-61
24. Gall A, Treuting P, Elkon KB, Loo YM, Gale M Jr, Barber GN, Stetson DB (2012) Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36:120-131
25. Izzotti A, Pulliero A, Orcesi S, Cartiglia C, Longobardi MG, Capra V, Lebon P, Cama A, La Piana R, Lanzi G et al (2009) Interferon-related transcriptome alterations in the cerebrospinal fluid cells of Aicardi-Goutières patients. Brain Pathol 19:650-660
26. Cuadrado E, Jansen MH, Anink J, De Filippis L, Vescovi AL, Watts C, Aronica E, Hol EM, Kuijpers TW (2013) Chronic exposure of astrocytes to interferon-alpha reveals molecular changes related to Aicardi-Goutières syndrome. Brain 136:245-258
27. Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T, Barnes DE (2004) Gene-targeted mice lacking the Trex1 (DNase III) 3′ - >5′ DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 24:6719-6727
28. Stetson DB, Ko JS, Heidmann T, Medzhitov R (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587-598
29. Crow YJ (2011) Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci 1238:91-98
30. Reijns MA, Rabe B, Rigby RE, Mill P, Astell KR, Lettice LA, Boyle S, Leitch A, Keighren M, Kilanowski F et al (2012) Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 149:1008-1022
31. Shaban NM, Harvey S, Perrino FW, Hollis T (2010) The structure of the mammalian RNase H2 complex provides insight into RNA. NA hybrid processing to prevent immune dysfunction. J Biol Chem 285:3617-3624
32. Reijns MA, Bubeck D, Gibson LC, Graham SC, Baillie GS, Jones EY, Jackson AP (2011) The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease. J Biol Chem 286:10530-10539
33. Bubeck D, Reijns MA, Graham SC, Astell KR, Jones EY, Jackson AP (2011) PCNA directs type 2 RNase H activity on DNA replication and repair substrates. Nucleic Acids Res 39:3652-3666
34. Cerritelli SM, Crouch RJ (2009) Ribonuclease H: the enzymes in eukaryotes. FEBS J 276:1494-1505
35. Hiller B, Achleitner M, Glage S, Naumann R, Behrendt R, Roers A (2012) Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med 209:1419-1426
36. Stein H, Hausen P (1969) Enzyme from calf thymus degrading the RNA moiety of DNA-RNA hybrids: effect on DNA-dependent RNA polymerase. Science 166:393-395
37. Machida Y, Okazaki T, Okazaki R (1977) Discontinuous replication of replicative form DNA from bacteriophage phiX174. Proc Natl Acad Sci U S A 74:2776-2779
38. Huertas P, Aguilera A (2003) Cotranscriptionally formed DNA: RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol Cell 12:711-721
39. Bhoj VG, Chen ZJ (2008) Linking retroelements to autoimmunity. Cell 134:569-571
40. Nick McElhinny SA, Kumar D, Clark AB, Watt DL, Watts BE, Lundstrom EB, Johansson E, Chabes A, Kunkel TA (2010) Genome instability due to ribonucleotide incorporation into DNA. Nat Chem Biol 6:774-781
41. Kim N, Huang SN, Williams JS, Li YC, Clark AB, Cho JE, Kunkel TA, Pommier Y, Jinks-Robertson S (2011) Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science 332:1561-1564
42. Brzostek-Racine S, Gordon C, Van Scoy S, Reich NC (2011) The DNA damage response induces IFN. J Immunol 187:5336-5345
43. Yang Y, Lindahl T, Barnes D (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131:873-886
44. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J (2010) The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 11:1005-1013
45. Yan N, Lieberman J (2011) Gaining a foothold: how HIV avoids innate immune recognition. Curr Opin Immunol 23:21-28
46. Beck-Engeser GB, Eilat D, Wabl M (2011) An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 8:91
47. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-661
48. Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T et al (2012) SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med 18:1682-1687
49. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW et al (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-382
50. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T et al (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223-228
51. Genovesio A, Kwon YJ, Windisch MP, Kim NY, Choi SY, Kim HC, Jung S, Mammano F, Perrin V, Boese AS et al (2011) Automated genome-wide visual profiling of cellular proteins involved in HIV infection. J Biomol Screen 16:945-958
52. Kennedy EM, Amie SM, Bambara RA, Kim B (2012) Frequent incorporation of ribonucleotides during HIV-1 reverse transcription and their attenuated repair in macrophages. J Biol Chem 287:14280-14288
53. Goodier JL, Kazazian HH Jr (2008) Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 135:23-35
54. Chiu YL, Greene WC (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 26:317-353